Foot-and-Mouth Disease

Foot-and-mouth disease (FMD) is an extremely contagious viral disease affecting cloven-hoofed animals, including cattle, sheep, goats, pigs, and many wildlife species. Caused by the foot-and-mouth disease virus (FMDV), an aphthovirus in the Picornaviridae family, this disease is considered one of the most economically devastating livestock diseases worldwide. FMD is characterized by fever and vesicular (blister) lesions on the mouth, tongue, lips, teats, and feet, though the presentation in sheep and goats is often much milder and less obvious than in cattle and pigs. This subtle presentation makes sheep and goats particularly dangerous as undetected reservoirs during outbreaks.

Foot-and-mouth disease occurs throughout much of Africa, Asia, the Middle East, and parts of South America, while North America, Western Europe, Australia, and New Zealand have been free of the disease through strict import controls and surveillance. The disease is classified as a notifiable disease by the World Organisation for Animal Health (WOAH), meaning any suspected case must be immediately reported to veterinary authorities. Seven serotypes of FMDV exist (O, A, C, Asia 1, and SAT 1, 2, and 3), with no cross-protection between serotypes, complicating vaccine development and outbreak response. The virus is highly mutable, with numerous subtypes and strains circulating globally.

The economic impact of foot-and-mouth disease is catastrophic, extending far beyond direct animal losses. Countries that experience outbreaks face immediate export bans on live animals and animal products, resulting in billions of dollars in trade losses. The 2001 United Kingdom outbreak resulted in the culling of over six million animals and estimated economic losses exceeding eight billion pounds. Beyond trade impacts, production losses from infected animals include reduced milk yield, impaired growth, abortion, and long-term sequelae affecting productivity. The social and emotional toll on farming communities affected by mandatory culling programs is profound and long-lasting.

Early detection of foot-and-mouth disease is critical for containing outbreaks and minimizing their impact. Because sheep and goats often show subtle signs that can be easily overlooked or attributed to other causes, veterinarians and producers must maintain high vigilance for this disease. Any suspicion of FMD must trigger immediate notification of animal health authorities, quarantine of premises, and initiation of investigation. Treatment of affected animals is prohibited in FMD-free countries, with control programs relying on culling, movement restrictions, and in some cases emergency vaccination. Understanding the unique presentation of FMD in small ruminants is essential for protecting national and international livestock industries.

Foot-and-mouth disease virus (FMDV) is the causative agent of FMD, classified as an aphthovirus within the Picornaviridae family. This non-enveloped, single-stranded RNA virus is highly infectious, with extremely small doses capable of initiating infection in susceptible hosts. The virus particle is icosahedral and approximately 25 nanometers in diameter. Seven serotypes (O, A, C, Asia 1, SAT 1, SAT 2, and SAT 3) are recognized, with serotype O being the most widely distributed globally. Importantly, infection with one serotype does not confer protection against others, and even within serotypes, multiple strains exist with varying degrees of cross-protection.

Genetic and species predisposition influences the clinical presentation and epidemiological significance of FMD. All cloven-hoofed animals are susceptible, but clinical severity varies dramatically between species. Cattle and pigs typically develop severe, obvious clinical disease, while sheep and goats often show mild or inapparent infection. This species difference makes small ruminants particularly dangerous during outbreaks, as they can harbor and spread the virus while appearing healthy. Within sheep, no clear breed predisposition to FMD has been established, though individual animals may show varying clinical severity. Goats may show slightly more obvious clinical signs than sheep in some outbreaks.

Environmental and management factors dramatically influence FMD transmission dynamics. The virus is extremely contagious, spreading through direct contact with infected animals, indirect contact with contaminated materials, and aerosol transmission over considerable distances. Under appropriate conditions, airborne virus can travel many kilometers, with documented spread of up to 60 kilometers over water. Contaminated vehicles, equipment, clothing, and animal products serve as fomites. The virus survives in the environment for extended periods under cool, humid conditions and persists in lymph nodes and bone marrow of infected carcasses. Intensive livestock systems with high animal densities facilitate rapid transmission. International trade in live animals and animal products represents the primary route for intercontinental spread.

Risk factors for FMD introduction and spread include proximity to endemic regions, importation of animals or animal products from affected areas, inadequate biosecurity, and contact with potentially contaminated people or materials. Countries that share borders with endemic regions face continuous introduction risk. Wildlife populations, particularly deer and wild pigs, can serve as reservoirs and complicate control efforts. Sheep movements, including attendance at markets and shows, can rapidly disseminate infection while animals appear healthy. The long incubation period in some species allows infected animals to be transported and spread virus before detection.

The pathophysiology of FMD involves initial virus replication in pharyngeal tissues following inhalation or ingestion of the virus. Primary viremia spreads the virus throughout the body, with secondary replication occurring in epithelial tissues of the mouth, feet, and mammary glands. Vesicular lesions develop as virus-induced cell damage causes separation of epithelial layers with fluid accumulation. In sheep, the epithelium is thinner than in cattle, and vesicles rupture quickly, making lesion detection more difficult. Virus shedding begins before clinical signs appear and continues throughout acute illness, with animals remaining infectious for days to weeks. Some cattle and small ruminants become carriers, harboring virus in the pharynx for months to years following apparent recovery.

Early warning signs of foot-and-mouth disease in sheep and goats are often subtle and easily overlooked, which is one of the most dangerous aspects of FMD in small ruminants. Initial signs may include mild depression, reluctance to move, slight fever, and reduced appetite that can be attributed to many common conditions. Careful observation may reveal slight salivation or lip smacking. Sheep may show subtle lameness that affects one or more feet without obvious external lesions. A key early indicator is sudden onset of lameness affecting multiple animals in a group simultaneously, which should immediately raise suspicion of vesicular disease. Producers and veterinarians must maintain high index of suspicion for FMD, especially when multiple animals show concurrent signs.

Common symptoms of FMD in sheep and goats are typically less dramatic than in cattle but follow similar patterns. Oral lesions, when visible, appear as vesicles (blisters) on the tongue, dental pad, gums, and lips, but these often rupture quickly leaving shallow erosions that heal rapidly. Salivation is usually less pronounced than in cattle. Foot lesions occur at the coronary band and in the interdigital cleft, causing varying degrees of lameness. In sheep, foot lesions may be the only clinical sign observed. Goats may show more pronounced oral lesions than sheep and can develop lesions on the teats. Young lambs and kids may develop myocarditis causing sudden death without prior clinical signs. Fever typically precedes vesicle development by one to two days.

Behavioral changes in FMD-affected sheep and goats include reluctance to move, separation from the flock, and reduced grazing activity. Affected animals may lie down more frequently and resist being moved. Lameness causes obvious gait abnormalities, with animals stepping gingerly or refusing to bear weight on affected limbs. Sheep with oral lesions may show reduced rumination and decreased feed intake. Animals may cluster in shade or near water. Nursing ewes and does with teat lesions may be reluctant to allow offspring to nurse, and may kick at lambs or kids attempting to feed. Overall flock behavior changes may be the first indication that something is wrong before individual cases are identified.

Physical signs of FMD in sheep and goats require careful examination to detect. Oral examination may reveal small vesicles or erosions on the tongue, particularly along the edges and tip, on the dental pad, and on the gums and lips. Because vesicles in sheep are fragile and short-lived, erosions or healing lesions may be all that remains by the time animals are examined. Foot examination reveals lesions at the coronary band, which may appear as separation of the horn from the underlying tissue, and in the interdigital space. Swelling around the coronary band and interdigital area may be apparent. Teat lesions appear as vesicles or erosions and can be confused with other causes of teat damage. Body temperature is elevated during early stages of infection.

Symptom progression in FMD typically begins with fever one to five days after exposure, followed by vesicle development over the next one to two days. Vesicles enlarge rapidly and rupture, leaving raw erosions that are painful and interfere with eating and walking. In sheep, the progression from vesicle to erosion occurs so rapidly that intact vesicles may never be observed. Lesions typically heal within one to two weeks in uncomplicated cases, though secondary bacterial infection can prolong recovery. Nail separation at the coronary band can lead to hoof sloughing in severe cases. Lactating animals show rapid decline in milk production. Abortion may occur in pregnant animals. Young animals are at risk of fatal myocarditis during the viremic phase.

Emergency symptoms requiring immediate action include any suspicion of vesicular disease in cloven-hoofed animals. Any observation of blisters, drooling, or sudden lameness affecting multiple animals must be reported immediately to veterinary authorities. Sudden death in young lambs or kids without prior illness warrants investigation for FMD-associated myocarditis. The critical point is that any clinical signs suggestive of FMD require immediate notification rather than waiting for definitive diagnosis. Delaying reporting to investigate other possible causes allows continued viral spread and dramatically worsens outbreak outcomes. Suspected premises must be quarantined immediately with no animal, person, or material movement until authorities arrive.

Clinical examination for foot-and-mouth disease must be conducted with extreme care due to the regulatory implications of suspected cases. Veterinary examination includes careful inspection of the oral cavity for vesicles, erosions, or healing lesions on the tongue, dental pad, gums, and lips. All four feet must be examined for lesions at the coronary band and in the interdigital space. Teats and udder should be inspected in lactating animals. Body temperature should be recorded. The examination should include assessment of multiple animals, as FMD typically affects many animals in a group simultaneously. Documentation of findings with photographs supports regulatory investigation. Importantly, clinical examination alone cannot definitively diagnose FMD, and laboratory confirmation is essential.

Laboratory diagnostic testing is required to confirm foot-and-mouth disease and initiate appropriate regulatory response. Sample collection should be performed by trained personnel using appropriate containment protocols to prevent further spread. Diagnostic samples include vesicular fluid or epithelial tissue from unruptured or recently ruptured vesicles, oropharyngeal (probang) samples for carrier detection, and blood samples for serology and viremia detection. Samples must be transported to approved laboratories under appropriate conditions. Diagnostic methods include virus isolation in cell culture, enzyme-linked immunosorbent assay (ELISA) for antigen detection, reverse transcription polymerase chain reaction (RT-PCR) for viral RNA detection, and serological tests for antibody detection. Serotyping is essential for identifying the specific virus strain involved.

Differential diagnosis for FMD includes other vesicular diseases and conditions that cause oral erosions and lameness in sheep and goats. Bluetongue causes oral erosions and lameness but typically with more pronounced systemic illness and characteristic cyanosis. Contagious ecthyma (orf) produces proliferative rather than vesicular lesions and typically affects younger animals. Foot rot causes interdigital lesions and lameness but without oral involvement. Ulcerative dermatosis causes ulcerative lesions but with different distribution. Photosensitization affects unpigmented skin. Sheep pox produces generalized skin lesions. Chemical or thermal burns can cause oral erosions. Because of the catastrophic implications of FMD, any vesicular disease must be investigated as potential FMD until laboratory results confirm an alternative diagnosis.

Flock-level diagnostic considerations during suspected FMD outbreaks include systematic examination of all animals to determine the extent of clinical disease. Recording the proportion of animals affected and the distribution of lesion types provides epidemiological information. Identifying the index case (first infected animal) helps trace the source of introduction. Assessing clinical progression in affected animals helps determine how long the virus has been present. Mapping the geographic distribution of affected premises identifies the outbreak extent. Testing apparently healthy animals, particularly sheep and goats that may show subclinical infection, is essential for understanding true infection prevalence. All diagnostic activities must be coordinated with animal health authorities conducting the regulatory investigation.

Regulatory and notification requirements for suspected FMD are strict and immediate. Any veterinarian or animal owner who observes clinical signs suggestive of FMD is legally obligated to notify animal health authorities immediately. In most countries, this means contacting the state or federal veterinarian. Suspected premises are immediately quarantined with complete standstill of animal movements. Only approved personnel using appropriate biosecurity procedures may enter or leave the premises. Sample collection and laboratory testing are conducted by official veterinary services. Trade implications begin immediately upon suspicion, with affected countries losing FMD-free status and associated market access. Understanding these regulatory requirements is essential for anyone working with livestock.

Emergency response to suspected foot-and-mouth disease does not involve treatment of affected animals but focuses on containment and notification. The first action upon suspecting FMD must be immediate notification of animal health authorities. Suspected premises must be isolated with complete standstill of all animal and human movement. No animals, equipment, vehicles, or materials should leave the premises. Personnel who have had contact with suspected animals should not visit other livestock premises. Animals should be isolated in place without moving them to treatment or examination areas. Documentation of all animals, human contacts, and recent movements from the premises supports regulatory investigation.

Medical management and treatment of FMD-affected animals is not permitted in countries that are FMD-free or conducting eradication programs. The policy of non-treatment exists because FMD is so contagious that allowing infected animals to survive prolongs viral shedding and increases transmission risk. Control strategies in FMD-free countries rely on stamping out through culling of infected and exposed animals, combined with movement restrictions and surveillance. In some endemic regions, treatment may be permitted under certain circumstances, but this is not relevant to non-endemic areas. Any supportive care or pain management that might be considered for other diseases is prohibited for FMD suspects pending laboratory results.

Surgical intervention has no role in FMD management because the disease is viral and systemic, and the control strategy does not involve individual animal treatment. The only relevant consideration is humane slaughter methods used during stamping-out operations. Animals confirmed or suspected to have FMD are culled humanely using approved methods including captive bolt stunning followed by exsanguination, or lethal injection where appropriate. Carcass disposal must prevent further environmental contamination, typically through burial, burning, or rendering at approved facilities. All disposal activities are conducted under official supervision with appropriate biosecurity measures.

Supportive care for FMD-affected animals is not provided in eradication programs because the goal is elimination of infected animals rather than recovery. In endemic regions where FMD is managed rather than eradicated, supportive care might include soft feeds for animals with oral lesions, clean bedding, and protection from environmental extremes. However, this approach is not applicable in FMD-free regions where suspected and confirmed cases are subject to mandatory culling. The welfare of animals during the investigation and culling process is addressed through timely decision-making and humane slaughter methods.

Herd management during FMD outbreaks involves strict quarantine, depopulation of affected and in-contact animals, and extensive cleaning and disinfection. All cloven-hoofed animals on affected premises are typically culled regardless of whether they show clinical signs, as apparently healthy animals may be incubating infection or acting as carriers. Contact premises where animals or fomites from infected premises have been present are also quarantined and investigated. Movement restrictions extend well beyond confirmed infected premises to create buffer zones around outbreak areas. Surveillance zones are established for enhanced monitoring. Cleaning and disinfection of premises must be completed before restocking can be considered.

Decision-making during FMD response involves regulatory authorities rather than individual producers or veterinarians. Once FMD is suspected, control authority transfers to official veterinary services operating under national contingency plans. Producers may be compensated for culled animals according to established programs, but do not have the option to retain or treat infected animals. Vaccination may be considered as part of outbreak response in some situations, but this decision is made at national or regional level based on outbreak characteristics and policy considerations. Emergency vaccination can reduce viral transmission but complicates subsequent demonstration of disease-free status.

Recovery timeline for premises affected by foot-and-mouth disease involves extended periods of quarantine, cleaning, and surveillance before normal operations can resume. Following depopulation of infected premises, thorough cleaning and disinfection must be completed according to official protocols. Initial cleaning removes all organic material that could harbor virus. Disinfection uses approved agents including citric acid, sodium hydroxide, or sodium carbonate that effectively inactivate FMDV. Multiple rounds of cleaning and disinfection may be required. Following completion of cleaning, premises typically remain empty for specified waiting periods, often 30 days or longer. Sentinel animals may be placed on cleaned premises and monitored to confirm effective disinfection before full restocking.

Post-outbreak care and monitoring at previously affected premises continues for extended periods after restocking. Newly introduced animals undergo enhanced surveillance for FMD signs. Regular veterinary inspections confirm continued freedom from disease. Serological testing may be required to demonstrate that animals have not been exposed. Movement restrictions on and off the premises may continue during surveillance periods. Documentation of animal health status and testing results supports demonstration of disease freedom. Producers must maintain heightened awareness and immediately report any suspicious signs.

Prognosis for individual animals is not relevant in FMD eradication programs because affected animals are culled rather than treated. In endemic regions where animals are not culled, most immunocompetent adults recover from clinical FMD within two to three weeks, though sequelae including chronic lameness, reduced productivity, and carrier status may persist. Some animals, particularly young stock, die from myocarditis or secondary complications. Recovery does not eliminate the risk of transmission, as carrier animals may harbor virus in the pharynx for months to years. For affected premises in eradication programs, the prognosis involves returning to normal operations after completing regulatory requirements rather than animal recovery.

Return to production following FMD outbreaks requires meeting extensive regulatory requirements before restocking and resuming normal operations. Premises must complete cleaning and disinfection protocols verified by official inspection. Waiting periods following disinfection must elapse. Sentinel animal placement and monitoring may be required. Sourcing replacement animals must comply with any ongoing movement restrictions and testing requirements. Insurance claims and compensation processes must be completed. Market access may be restricted until regional or national disease-free status is restored. The timeline for full return to normal operations often extends many months beyond initial outbreak control. Psychological recovery for affected producers and communities is also an important consideration given the traumatic nature of FMD outbreaks.

Vaccination protocols for foot-and-mouth disease exist and are used in endemic regions for ongoing control and in FMD-free regions during emergency outbreak response. Vaccines contain inactivated virus and must be matched to the specific serotype and strain circulating in the region. Multiple serotypes may require polyvalent vaccines. Vaccination requires booster doses at appropriate intervals to maintain immunity. In endemic regions, routine vaccination reduces clinical disease and viral circulation but does not eliminate the virus. In FMD-free regions, vaccination is controversial because vaccinated animals cannot be serologically distinguished from infected animals without specialized testing, complicating subsequent demonstration of disease-free status. Emergency vaccination may be deployed during outbreaks as a ring vaccination around infected premises or more broadly to reduce transmission.

Biosecurity measures are the primary defense against FMD introduction to free regions and premises. National-level biosecurity includes strict import controls on live animals and animal products from endemic regions, prohibition on feeding food waste containing meat products to livestock, and border inspections. Farm-level biosecurity includes controlling access to premises, preventing contact between livestock and wild animals, cleaning and disinfecting vehicles and equipment, and requiring visitors to use clean clothing and footwear. Avoiding contact with livestock when returning from travel to endemic regions is essential. Personal items including clothing and footwear that contacted animals abroad should be thoroughly cleaned or left behind.

Nutritional prevention does not directly prevent FMD infection, but maintaining animals in good body condition and nutritional status supports immune function and overall health. Well-nourished animals may respond better to vaccination where this is practiced. Good nutrition supports recovery in endemic regions where animals are not culled. However, no nutritional intervention can substitute for biosecurity and vaccination in FMD prevention. The focus of prevention must remain on excluding the virus from premises and populations.

Management practices that reduce FMD risk include maintaining closed herds with minimal animal introductions, quarantining and testing new arrivals, avoiding livestock markets and shows in high-risk periods, and maintaining awareness of global FMD situation. Producers should know the clinical signs of FMD and report any suspicious cases immediately. Participating in official disease surveillance programs supports early detection. Maintaining relationships with veterinarians familiar with foreign animal diseases ensures expert consultation is available if needed. Planning for continuity during potential outbreaks, including business interruption insurance and emergency contacts, improves resilience.

Quarantine and testing protocols for FMD prevention focus on controlling animal movements and maintaining awareness of disease status. Animals imported from endemic regions must undergo extended quarantine with testing before release. Within FMD-free regions, quarantine of new animals with careful observation provides an opportunity to detect incubating disease. Serological testing can detect previous exposure but cannot identify all carriers. Producers should document animal movements and contacts to enable rapid tracing if disease is detected. Official movement recording systems in many countries support traceability. Participation in voluntary testing and surveillance programs demonstrates commitment to disease freedom and supports market access.

Daily management and monitoring for FMD prevention requires integration of biosecurity practices into routine operations. Observing animals daily for any signs of vesicular disease, lameness, or reduced appetite enables early detection of potential FMD cases. Controlling access to livestock areas prevents introduction of contaminated materials. Maintaining visitor logs supports contact tracing if disease is detected. Cleaning and disinfecting shared equipment between uses reduces fomite transmission risk. Monitoring for any unusual disease patterns in the area through contact with veterinarians and agricultural networks maintains situational awareness. These practices become routine with consistent implementation.

Housing and environmental management influence FMD transmission risk primarily through their effects on biosecurity. Physical barriers including fences and walls prevent contact between domestic livestock and wild ruminants that could carry FMD. Secure perimeters prevent unauthorized entry by people, animals, or vehicles that could introduce contamination. Dedicated livestock handling areas away from public access points reduce exposure opportunities. Foot baths and vehicle disinfection stations at entry points provide additional protection when properly maintained and used. Good drainage prevents pooling of potentially contaminated water. While environmental factors cannot prevent FMD if the virus is introduced, good facility design supports effective biosecurity implementation.

Herd health programs addressing FMD focus on surveillance, biosecurity compliance, and preparedness rather than disease management within the herd. Working with veterinarians to develop and review biosecurity protocols ensures that practices remain effective and current. Participating in official surveillance programs through regular veterinary visits and testing demonstrates disease-free status. Training personnel to recognize FMD signs and understand reporting requirements enables rapid response to suspicious cases. Conducting tabletop exercises for disease response scenarios improves preparedness. Integrating FMD awareness into general herd health management maintains vigilance without creating undue anxiety.

Record keeping and monitoring systems support both FMD prevention and response if disease occurs. Maintaining accurate records of all animals on premises enables rapid assessment during disease investigations. Documenting animal movements onto and off the premises supports traceability. Recording visitor contacts, vehicle entries, and equipment sharing provides contact tracing information. Keeping veterinary records including examinations and treatments demonstrates ongoing animal health monitoring. Maintaining inventory of inputs including feed sources provides information relevant to disease investigation. Electronic record systems facilitate rapid retrieval and analysis of information during emergency response.

Economic considerations for FMD prevention include the costs of maintaining biosecurity versus the catastrophic consequences of disease incursion. Biosecurity investments including facility improvements, protocols, and training represent ongoing costs that may seem difficult to justify when disease is absent. However, the economic devastation of FMD outbreaks, including animal losses, business interruption, and lost market access, far exceeds prevention costs. Insurance products may be available for business interruption during disease outbreaks. Government compensation programs exist for animals culled during eradication programs but rarely cover all losses. The value of maintaining FMD-free status extends beyond individual operations to national agricultural economies and export markets.

High-risk breeds for severe foot-and-mouth disease have not been clearly established, as all cloven-hoofed domestic animals are susceptible regardless of breed. The more important consideration for sheep and goats is that these species typically show mild or inapparent clinical signs compared to cattle and pigs, making them epidemiologically dangerous as undetected virus reservoirs. Within sheep, various breeds show similar susceptibility to infection, though clinical expression may vary. Dairy goat breeds may show more obvious clinical signs than sheep due to teat lesions affecting milk production. High-producing dairy animals may show more severe clinical disease due to the metabolic demands of lactation. Young stock of all breeds are at risk of fatal myocarditis.

Production type considerations significantly influence FMD risk and impact. Intensive livestock operations with high animal densities face rapid within-herd transmission once virus is introduced. Mixed species operations with cattle, sheep, and goats together have complex epidemiological dynamics, as different species show different clinical presentations. Dairy operations face particular challenges because teat lesions affect milk production and milking equipment can spread infection. Operations near international borders or ports of entry may face elevated introduction risk. Pastoralist and extensive grazing operations have difficulty implementing biosecurity but may have lower within-herd transmission due to reduced animal density. Show and breeding operations with frequent animal movements and contacts face elevated exposure risk.

Genetic selection and testing for FMD resistance have not been developed as practical tools, and the eradication strategy in FMD-free regions makes individual animal resistance largely irrelevant. Research has identified some genetic factors that may influence FMD susceptibility and clinical severity, but these findings have not translated into selection programs. The primary genetic consideration for FMD is that all cloven-hoofed species share susceptibility to the virus, making multi-species biosecurity essential. Rather than selecting for resistance, the focus remains on excluding the virus through biosecurity and eliminating it through stamping out when it occurs.

Commonly co-occurring conditions with foot-and-mouth disease include secondary bacterial infections that complicate viral lesions. Bacterial invasion of damaged epithelium can cause more severe tissue destruction and delayed healing. Foot rot organisms may opportunistically infect FMD foot lesions. Mastitis can develop secondary to teat lesions. Myocarditis is a primary complication of FMD itself, particularly affecting young animals and sometimes causing sudden death. Abortion occurs in pregnant animals. Secondary pneumonia may develop in debilitated animals. However, because FMD cases in eradication programs are culled, progression to these complications is typically prevented.

Conditions with similar symptoms that must be differentiated from foot-and-mouth disease include several other causes of vesicular disease and oral or foot lesions. Bluetongue causes oral erosions and lameness but with characteristic cyanosis and systemic illness. Contagious ecthyma (orf) produces proliferative rather than vesicular lesions with characteristic progression. Vesicular stomatitis, present in the Americas, causes identical vesicular lesions and must be considered in differential diagnosis. Swine vesicular disease in pigs is clinically indistinguishable from FMD. Foot rot causes interdigital lesions without oral involvement. Photosensitization causes lesions on unpigmented skin. Chemical burns produce lesions at contact sites. Any condition that could be mistaken for FMD must be definitively ruled out through laboratory testing.

Complications and sequelae of foot-and-mouth disease in animals that survive (in endemic regions where culling is not practiced) include chronic lameness from hoof damage, reduced milk production, poor growth rates, and carrier status. Myocarditis survivors may have permanent cardiac damage. Reproductive losses from abortion and neonatal deaths reduce subsequent productivity. The carrier state, in which virus persists in pharyngeal tissues for months to years, poses ongoing risk of transmission to susceptible animals. At the herd and regional level, FMD complications include massive economic losses, trade restrictions, social disruption, and long-term psychological impacts on affected farming communities. Recovery of FMD-free status following outbreaks requires extended demonstration periods with intensive surveillance.